This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Looijenga, L. H. Articles by Oosterhuis, J. W. Search for Related Content PubMed PubMed Citation Articles by Looijenga, L. H. Articles by Oosterhuis, J. W.

American Journal of Pathology, Vol 151, 581-590, Copyright © 1997 by American Society for Investigative Pathology

REGULAR ARTICLES

X inactivation in human testicular tumors. XIST expression and androgen receptor methylation status

LH Looijenga, AJ Gillis, RJ van Gurp, AJ Verkerk and JW Oosterhuis
Laboratory for Experimental Patho-Oncology, Dr. Daniel den Hoed Cancer Center, Academic Hospital Rotterdam, The Netherlands.

In female mammalian cells, inactivation of one of the X chromosomes compensates the increased dosage of X-linked genes as compared with their male counterparts. This process is initiated by the X-inactive specific transcripts of the xist/XIST gene in cis, resulting in methylation of specific sites of genes to be silenced. However, in male germ cells, X inactivation is established by xist/XIST expression only. We investigated the X inactivation pattern in human testicular tumors of different histogenesis by analysis of XIST expression and methylation of the androgen receptor gene. XIST was expressed only in tumors derived from the germ cell lineage with supernumerical X chromosomes: seminomas, nonseminomas, and spermatocytic seminomas. Although low expression was present in testicular parenchyma with spermatogenesis, XIST was expressed at a higher level in parenchyma with carcinoma in situ, the precursor lesion of seminomas and nonseminomas. Despite the consistent expression of XIST in germ-cell- derived tumors with gain of X chromosomes, methylation of the androgen receptor gene was present in all differentiated but only in a proportion of the undifferentiated nonseminomas. This differential pattern of methylation was also found in a number of representative cell lines. Our data indicate that the counting mechanism resulting in X inactivation is functional in testicular cancers of different histogenesis. Moreover, the differentiation-dependent pattern of X inactivation as reported during normal development in the case of multiple X chromosomes by methylation is retained in these tumors. We conclude therefore that X inactivation allows the excessive gain of X chromosomes found in germ-cell-derived tumors of the adult testis. In addition, this offers an interesting model to study the fundamental mechanisms of these processes.

This article has been cited by other articles:

				L. H. J. LOOIJENGA, AD. J. M. GILLIS, H. J. STOOP, R. HERSMUS, and J. W. OOSTERHUIS Chromosomes and Expression in Human Testicular Germ-Cell Tumors: Insight into Their Cell of Origin and Pathogenesis Ann. N.Y. Acad. Sci., December 1, 2007; 1120(1): 187 - 214. [Abstract] [Full Text] [PDF]

				F. Savarese, K. Flahndorfer, R. Jaenisch, M. Busslinger, and A. Wutz Hematopoietic precursor cells transiently reestablish permissiveness for x inactivation. Mol. Cell. Biol., October 1, 2006; 26(19): 7167 - 7177. [Abstract] [Full Text] [PDF]

				E. Rajpert-De Meyts Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects Hum. Reprod. Update, May 1, 2006; 12(3): 303 - 323. [Abstract] [Full Text] [PDF]

				L. Aksglaede, A. M. Wikstrom, E. R.-D. Meyts, L. Dunkel, N. E. Skakkebaek, and A. Juul Natural history of seminiferous tubule degeneration in Klinefelter syndrome Hum. Reprod. Update, January 1, 2006; 12(1): 39 - 48. [Abstract] [Full Text] [PDF]

				C.E. Hoei-Hansen, J.E. Nielsen, K. Almstrup, M.A. Hansen, N.E. Skakkebaek, E. Rajpert-DeMeyts, and H. Leffers Identification of genes differentially expressed in testes containing carcinoma in situ Mol. Hum. Reprod., June 1, 2004; 10(6): 423 - 431. [Abstract] [Full Text] [PDF]

				L. H. J. Looijenga, H. Stoop, H. P. J. C. de Leeuw, C. A. de Gouveia Brazao, A. J. M. Gillis, K. E. P. van Roozendaal, E. J. J. van Zoelen, R. F. A. Weber, K. P. Wolffenbuttel, H. van Dekken, et al. POU5F1 (OCT3/4) Identifies Cells with Pluripotent Potential in Human Germ Cell Tumors Cancer Res., May 1, 2003; 63(9): 2244 - 2250. [Abstract] [Full Text] [PDF]

				A.-M. F. Kersemaekers, F. Mayer, M. Molier, P. C. van Weeren, J. W. Oosterhuis, C. Bokemeyer, and L. H.J. Looijenga Role of P53 and MDM2 in Treatment Response of Human Germ Cell Tumors J. Clin. Oncol., March 15, 2002; 20(6): 1551 - 1561. [Abstract] [Full Text] [PDF]

				G. Zafarana, A. J. M. Gillis, R. J. H. L. M. van Gurp, P. G. Olsson, F. Elstrodt, H. Stoop, J. L. Millan, J. W. Oosterhuis, and L. H. J. Looijenga Coamplification of DAD-R, SOX5, and EKI1 in Human Testicular Seminomas, with Specific Overexpression of DAD-R, Correlates with Reduced Levels of Apoptosis and Earlier Clinical Manifestation Cancer Res., March 1, 2002; 62(6): 1822 - 1831. [Abstract] [Full Text] [PDF]

				C. Bokemeyer, A. J.M. Gillis, K. Pompe, F. Mayer, B. Metzner, N. Schleucher, J. Schleicher, G. Pflugrad-Jauch, J. W. Oosterhuis, L. Kanz, et al. Clinical Impact of Germ Cell Tumor Cells in Apheresis Products of Patients Receiving High-Dose Chemotherapy J. Clin. Oncol., June 15, 2001; 19(12): 3029 - 3036. [Abstract] [Full Text] [PDF]